11.52
Schlusskurs vom Vortag:
$11.37
Offen:
$11.5
24-Stunden-Volumen:
16.22M
Relative Volume:
0.51
Marktkapitalisierung:
$6.16B
Einnahmen:
$1.55B
Nettoeinkommen (Verlust:
$229.66M
KGV:
27.16
EPS:
0.424
Netto-Cashflow:
$311.55M
1W Leistung:
-1.60%
1M Leistung:
+3.09%
6M Leistung:
+2.37%
1J Leistung:
+17.05%
Uipath Inc Stock (PATH) Company Profile
Firmenname
Uipath Inc
Sektor
Branche
Telefon
(844) 432-0455
Adresse
ONE VANDERBILT AVENUE, NEW YORK
Compare PATH vs MSFT, ORCL, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PATH
Uipath Inc
|
11.52 | 6.08B | 1.55B | 229.66M | 311.55M | 0.424 |
|
MSFT
Microsoft Corporation
|
398.21 | 2.98T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
155.56 | 457.44B | 64.08B | 16.40B | -24.74B | 5.5698 |
|
PLTR
Palantir Technologies Inc
|
149.10 | 367.12B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
435.49 | 111.98B | 4.81B | -181.85M | 1.24B | -0.7398 |
|
SNPS
Synopsys Inc
|
410.99 | 80.21B | 8.00B | 1.10B | 2.28B | 6.4708 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-02 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Neutral |
| 2025-03-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-12 | Eingeleitet | UBS | Sell |
| 2024-06-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-05-30 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-30 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-04-08 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-03-14 | Bestätigt | Needham | Buy |
| 2024-02-21 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-01-02 | Eingeleitet | William Blair | Outperform |
| 2023-06-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-04-21 | Eingeleitet | DA Davidson | Neutral |
| 2023-03-16 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-09-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-01-25 | Hochstufung | Macquarie | Neutral → Outperform |
| 2022-01-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-09 | Hochstufung | Berenberg | Hold → Buy |
| 2021-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-12 | Eingeleitet | Summit Insights | Sell |
| 2021-05-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-05-17 | Eingeleitet | Barclays | Equal Weight |
| 2021-05-17 | Eingeleitet | BofA Securities | Buy |
| 2021-05-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-05-17 | Eingeleitet | Cowen | Outperform |
| 2021-05-17 | Eingeleitet | DA Davidson | Buy |
| 2021-05-17 | Eingeleitet | Evercore ISI | In-line |
| 2021-05-17 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-17 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-17 | Eingeleitet | Macquarie | Neutral |
| 2021-05-17 | Eingeleitet | Mizuho | Buy |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-17 | Eingeleitet | Needham | Buy |
| 2021-05-17 | Eingeleitet | Oppenheimer | Perform |
| 2021-05-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-05-17 | Eingeleitet | Truist | Buy |
| 2021-05-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-05-17 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-05-13 | Eingeleitet | Berenberg | Hold |
Alle ansehen
Uipath Inc Aktie (PATH) Neueste Nachrichten
UiPath: Not Living Up To Its Agentic Potential - Nanalyze
UiPath Inc. (NYSE:PATH) Q4 2026 Earnings Call Transcript - Insider Monkey
UiPath (PATH) Profitability Milestone Tests Bearish Earnings Decline Narrative - simplywall.st
UiPath Earnings Call: Profits Rise as AI Drives Growth - TipRanks
UiPath Earnings: Profitability Inflection Signals A Disciplined AI-Powered Future - Trefis
UiPath Execs Hid Risks, Ditched $394M+ In Stock, Suit Alleges - Law360
UiPath fell on good news-that could be the opportunity - MSN
UiPath, Deloitte launch AI-powered ERP automation offering - Investing.com
UiPath Fell on Good News—That Could Be the Opportunity - MarketBeat
UiPath And Deloitte Expand Alliance to Launch Agentic ERP - marketscreener.com
Market movers: Petco, UiPath, Bumble, Dollar General… - Proactive financial news
UiPath's AI Automation Model is Driving Platform-Level Efficiency - Yahoo Finance
UiPath Earnings: Profitability Milestone And AI Momentum Signal Execution Strength - Trefis
UiPath (NYSE:PATH) Price Target Lowered to $13.00 at TD Cowen - MarketBeat
UiPath (NYSE:PATH) Price Target Cut to $15.00 by Analysts at Canaccord Genuity Group - MarketBeat
UiPath Stock Faces Pressure Amid Price Target Cut - StocksToTrade
UiPath Analysts Slash Their Forecasts After Q4 Results - Benzinga
UiPath stock: why sell-off makes sense despite Q4 beat and buyback - Invezz
UiPath Q4 2026 slides: historic profitability, revenue beat offsets EPS miss - Investing.com Nigeria
PATH and Agentic AI: How UiPath's Platform Shift Could Pay Off - TradingView
UiPath Q4 2025 Earnings Beat Forecasts Amid AI-Driven GrowthNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
UiPath margins shine as AI fuels growth - Yahoo Finance
UiPath Stock Sinks 6% — But It Could Still Be the Next Palantir - Yahoo Finance
UiPath (NYSE:PATH) Price Target Cut to $13.00 by Analysts at DA Davidson - MarketBeat
UiPath stock drops after earnings. Why the software play can’t outrun AI fears. - MSN
BofA cuts UiPath stock price target on growth concerns to $12 - Investing.com
William Blair reiterates UiPath stock rating after Q4 results - Investing.com
PATH Q4 Deep Dive: AI Expansion and Margin Progress Offset by Cautious Outlook - StockStory
UiPath Stock Drops After Earnings. Why the Software Play Can’t Outrun AI Fears. - Barron's
What's Going On With UiPath (PATH) Stock Today?UiPath (NYSE:PATH) - Benzinga
Evercore ISI cuts UiPath stock price target on AI monetization uncertainty - Investing.com Nigeria
UiPath stock holds Sector Weight rating at KeyBanc on ARR guidance - Investing.com
Wells Fargo & Company Issues Pessimistic Forecast for UiPath (NYSE:PATH) Stock Price - MarketBeat
UiPath Stock Price Falls as 2027 Growth Outlook Overshadows Q4 Beat, $500 Million Buyback - TechStock²
UiPath plunges after Q4 results, but Needham upgrades to buy on new ARR - MSN
Why Is UiPath (PATH) Stock Down Premarket Today Despite an Earnings Beat? - Tokenist
UiPath plunges after Q4 results, but Needham upgrades to Buy on new ARR - Seeking Alpha
Stock Market Today: S&P 500, Dow Futures Fall Amid Narrowing Trade Deficit, Jobless Claims Dip— Bumble, Morgan Stanley, Adobe In Focus (UPDATED) - Benzinga
Morgan Stanley Lowers UiPath (NYSE:PATH) Price Target to $17.00 - MarketBeat
UiPath’s AI automation story is not translating into faster growth yet, say UBS, Morgan Stanley analysts - MSN
UiPath’s AI Automation Story Is Not Translating Into Faster Growth Yet, Say UBS, Morgan Stanley Analysts - Stocktwits
Needham upgrades UiPath stock rating to buy on growth outlook - Investing.com
UiPath (PATH) Stock Slides 5% Despite Crushing Earnings on Every Metric - MEXC
S&P 500 Futures Fall in Premarket Trading; UiPath, Piper Sandler Lag - Barron's
UiPath Stock Falls 8% After Weak Q4 Outlook Misses Investor Expectations - TIKR.com
UiPath dips despite revenue beat, as guidance fails to excite analysts about longer-term growth - Sherwood News
UiPath Stock Tumbles as Guidance Fails to Excite Investors - TradingView
UiPath targets $2B ARR milestone in FY27 as AI adoption accelerates, updates long-term margin goal - MSN
UBS cuts UiPath stock price target to $13 on growth concerns - Investing.com
UiPath (PATH) Stock Drops 5% Following Strong Q4 Earnings Beat - Blockonomi
Truist cuts UiPath stock price target on valuation concerns - Investing.com
Finanzdaten der Uipath Inc-Aktie (PATH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):